- +170.8% price growth over the last year
- High gross margin of 89.9%
- Strong return on equity of 121.5%
UroGen Pharma Ltd stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Updated on Jul 10, 2026)
The UroGen Pharma Ltd stock price fell by -4.15% on the last day (Friday, 10th Jul 2026) from $40.23 to $38.56. During the last trading day the stock fluctuated 4.30% from a day low at $38.39 to a day high of $40.04. The price has risen in 8 of the last 10 days and is up by 12.16% over the past 2 weeks. Volume has increased on the last day by 557 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $45.26 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 62.60% during the next 3 months and, with a 90% probability hold a price between $53.21 and $65.83 at the end of this 3-month period.
URGN Signals & Forecast
The UroGen Pharma Ltd stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $38.28 and $32.18. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -4.15%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for UroGen Pharma Ltd stock
On the downside, the stock finds support just below today's level from accumulated volume at $34.54 and $31.33. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, UroGen Pharma Ltd finds support just below today's level at $34.54. If this is broken, then the next support from accumulated volume will be at $31.33 and $29.40.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.65 between high and low, or 4.30%. For the last week, the stock has had daily average volatility of 5.22%.
Our recommended stop-loss: $36.96 (-4.16%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (URGN) For The Upcoming Trading Day Of Monday 13th
For the upcoming trading day on Monday, 13th we expect UroGen Pharma Ltd to open at $39.00, and during the day (based on 14 day Average True Range), to move between $37.63 and $39.49, which gives a possible trading interval of +/-$1.86 (+/-4.93%) up or down from last closing price. If UroGen Pharma Ltd takes out the full calculated possible swing range there will be an estimated 4.93% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $40.23 (4.33%) than the support at $34.54 (10.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is UroGen Pharma Ltd stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for UroGen Pharma Ltd stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
1.532
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 13, 2026 - $39.00 ( 1.13%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
URGN Performance
Trading levels for URGN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 40.65 | 5.41% |
| R2 | 40.02 | 3.78% |
| R1 | 39.63 | 2.77% |
| Price | 38.56 | |
| S1 | 38.37 | -0.502% |
| S2 | 37.98 | -1.51% |
| S3 | 37.35 | -3.15% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 40.23 | 4.33% |
| Price | 38.56 | |
| S1 | 34.54 | -10.43% |
| S2 | 31.33 | -18.75% |
| S3 | 29.40 | -23.76% |
FAQ
Click here for our free guide on how to buy UroGen Pharma Ltd Stock.
Buy URGN